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ARTICLE
Myotonic dystrophy type 1: frequency of 
ophthalmologic findings
Distrofia miotônica tipo 1: frequência dos achados oftalmológicos
Karin Suzete Ikeda1, Cristina Iwabe-Marchese2, Marcondes Cavalcante França Jr.2, Anamarli Nucci2, Keila 
Monteiro de Carvalho1 
Myotonic dystrophy type 1 (DM1) is a cytosine-thymine-guanine 
[CTG]n triplet disorder inherited as autosomal dominant 
mode with multisystem variable expression. CTGn repeat oc-
curs in the 3’ untranslated region of the myotonin protein ki-
nase gene (MDPK) on chromosome 19q1,2,3. Toxic RNA tran-
scripts accumulate in the nucleus due to aberrant splicing and 
lead to abnormal expression of several proteins due to seques-
tration of nuclear transcription factors4.
A variety of ocular signs is described in DM1 patients, like 
cataract, retinal degeneration, low intraocular pressure (IOP), 
eyelid ptosis, epiphora, corneal lesions, extraocular myotonia, 
extraocular muscle weakness, abnormal central control of 
eye movement5. Cataract is one of the most important and 
distinctive feature of the disease5 and it may alert about the 
underlying disease5. Therefore, ophthalmologists can help to 
detect DM1 patients6,7,8, to refer patients for an appropriate 
diagnosis, for monitoring and genetic counseling8. Also, they 
can help to provide the best assistance to DM1 patients, for 
instance, restoring their visual acuity.
 Our aim was to analyze the frequency of ophthalmologi-
cal findings in a cohort of DM1 patients followed up in a uni-
versity hospital and to identify possible correlations of these 
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ABSTRACT
The purpose of the study was to evaluate the frequency of ophthalmologic abnormalities in a cohort of myotonic dystrophy type 1 (DM1) 
patients and to correlate them with motor function. We reviewed the pathophysiology of cataract and low intraocular pressure (IOP). 
Method: Patients were included after clinical and laboratory diagnosis and after signed informed consent. They were evaluated by Motor 
Function Measure scale, Portuguese version (MFM-P) and ophthalmic protocol. Results: We evaluated 42 patients aged 17 to 64 years 
(mean 40.7 ± 12.5), 22 of which were men. IOP (n = 41) was reduced in all but one. We found cataract or positivity for surgery in 38 (90.48%) 
and ptosis in 23 (54.76%). These signs but not IOP were significantly correlated with severity of motor dysfunction. Abnormalities in ocular 
motility and stereopsis were observed. Conclusion: Cataract and ptosis are frequent in DM1 and associated to motor dysfunction. Reduced 
IOP is also common, but appears not to be related with motor impairment.
Keywords: myotonic dystrophy type 1, cataract, eyelid ptosis, intraocular pressure, Motor Function Measure scale, Portuguese version. 
RESUMO
O objetivo do estudo foi avaliar a frequência das anormalidades oftalmológicas em uma coorte de pacientes com distrofia miotônica 
tipo 1 (DM1) correlacionando-as à função motora. Revisamos a fisiopatogenia da catarata e baixa pressão intraocular (PIO). Método: Os 
pacientes foram incluídos após diagnóstico clínico-laboratorial de DM1. Aqueles que assinaram o termo de participação foram 
avaliados pela escala medida da função motora, versão em português (MFM-P) e protocolo oftalmológico. Resultados: Avaliamos 
42 pacientes de 17 a 64 anos (média 40,7 ± 12,5), 22 do sexo masculino. Encontramos catarata ou positividade de cirurgia em 38 
(90,48%) e blefaroptose em 23 (54,76%) e esses sinais foram correlacionados significativamente à maior gravidade da disfunção 
motora. Baixa PIO também foi comum e não correlacionada à gravidade motora. Alterações da motilidade ocular e de estereopsia 
ocorreram. Conclusão: Catarata e ptose palpebral são frequentes na DM1 e associadas à gravidade motora. Baixa PIO é comum e 
parece ser independente da evolução motora.  
Palavras-chave: distrofia miotônica tipo 1, catarata, ptose palpebral, pressão  intraocular,  escala Medida da Função Motora, versão 
em português.
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abnormalities with motor dysfunction. We also reviewed the 
pathogenesis of cataract and low IOP.
METhOd
A descriptive study was carried out from February 
2013 to January 2014. Consecutive patients diagnosed 
with DM1, from the Neuromuscular outpatient Clinic at 
UNICAMP University Hospital were invited to partici-
pate in the study. This study was approved by the Ethics 
Committee in Research of the Faculty of Medical Sciences, 
UNICAMP, under the protocol no. 143.693/2012. Each pa-
tient signed a written informed consent before any study-
related procedure.
Diagnosis of DM1 was based on clinical phenotype, 
including distinct facial findings, facial, cervical and pre-
dominant distal weakness and atrophy, associated with 
action and percussion miotonia.  Patients were also sub-
mitted to the motor function measure scale, Portuguese 
version (MFM-P)9 and ancillary exams including cre-
atinekinase, electroneuromyography and routine labo-
ratory tests. MFM-P scale includes 32 items, rated on 
a 4-point scale (0 to 3; 3  =  completes the exercise in the 
standard normal pattern) and 3 dimensions (D1 = stand-
ing position and transfers; D2  =  axial and proximal 
function; D3  =  distal function). The total and sub scores 
are expressed as percentage of the highest possible score. 
DNA analysis was available in n = 25 patients. In most of 
these patients, screening for DMPK expansions was per-
formed using the TP-PCR technique, which is a sensitive 
method but does not enable precise quantification of the 
CTG repeat length. The remaining patients did not have 
molecular testing, but for all of them there was at least one 
family member with a positive test and a clear autosomal 
dominant pattern of inheritance.
They were submitted to an ophthalmologic protocol 
that included: visual acuity, refraction, visual field con-
frontation, clinical color vision evaluation using Ishihara 
test, lid position, pupillary reflex, measurement of IOP, 
slit lamp biomicroscopy, fundus examination, motil-
ity measurements, stereopsis test, nystagmus evalua-
tion. Visual acuity was considered with the best correc-
tion and Snellen visual acuity was converted to LogMAR 
acuity10. Refraction in patients under 18 years-old was 
performed 30 minutes after the instillation of 1% cyclo-
pentolate. Color vision was assessed by Ishihara’s test 
for color deficiency, 24 plates; 2007 edition, Kanehara 
Trading Inc., Tokyo, Japan. Slit lamp biomicroscopy used 
Haag-Streit aparatus (Koeniz, Suiss). Dilated fundus 
examination was performed after instillation of tropi-
camide 1% and phenylephrine 10%, using a 78 diopter 
lens in a Volk Optical, Mentor (Ohio, USA). IOP was re-
corded with Goldmann applanation tonometry (model 
R900, Haag-Streit, Koeniz, Suiss) after topical anesthesia 
with one drop of tetracaine 1% and phenylephrine 0.1% 
and instillation of one drop of fluorescein 1%. Ocular mo-
tility evaluation: the angles of deviation were measured 
with the best optical correction in place for the distance 
and the near and cardinal gaze positions. The measure-
ments were made using the simultaneous and alternate-
cover tests. The Krimsky test was employed when the 
cover tests were not applicable. Ductions, versions and 
diplopia were also evaluated. Stereopsis was assessed us-
ing Titmus Stereo Fly, Circles and Animals Test (Stereo 
Optical Co., Inc., Chicago). Occasional patients were not 
able to complete some parts of the examination proto-
col, but the remaining tests performed were all consid-
ered for further analyses.
Statistical analysis was performed using MS-Excel 
(MS-Office 2010) for data organization and IBM SPSS 
(Statistical Package, version 22.0) for Spearman correla-
tion test and Mann-Whitney test. Significance level was 
considered < 0.05.
RESUlTS
Forty-two patients were enrolled in the study, with ages 
ranging from 17 to 64 years (mean = 40.7 ± 12.5), median 43.5. 
There were 20 men and 22 women.
Cataract or prior phacoemulsification in at least one 
eye was detected in 38 patients (90.48%). Mean age at cat-
aract diagnosis was 40.2 ± 10.9 years. Among 28 (73.65%) 
patients that had the diagnosis of cataract made in our 
institution, two had visual acuity worse than 0.3 and were 
submitted to surgery and the others are still in visual mon-
itoring. Ten patients with cataracts were followed up out-
side the institution and four (40%) were operated. Four 
patients (9.52%) in the cohort had no signs of cataract in 
either eye. These were one woman and three men aged 17, 
20, 23 and 30 years, respectively.
A detailed frequency of ophthalmological findings in the 
cohort is displayed in Table 1. Ishihara’s vision color test was 
normal in all fourteen patients examined. Nystagmus was 
absent in 34 patients (80.95%); the remaining 8 (19.05%) had 
physiological nystagmus. None of the subjects presented 
pathological nystagmus.
The results of MFM-P scale are shown in Table 2 and 
Figure. Statistical analysis revealed a significant correla-
tion between MFM-P and age (r  =  -0.668; p  <  0.001), but 
no correlation between IOP and MFM-P considering each 
eye.  MFM-P also had a significant correlation with Titmus 
test (r = -0.467, p = 0.007). Patients with cataracts had low-
er MFM-P scores in comparison to those patients without 
cataracts (75.9 ± 14.5 vs 95.8 ± 2.7, p  =  0.019). In addition, 
ptosis was also associated with lower total MFM-P scores 
(73.1 ± 15.2 vs 84.5 ± 12.2, p = 0.031).
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diSCUSSiOn
In the DM1 cohort we observed a high frequency of cat-
aract and low IOP, the first sign with significant correlation 
with MFM-P. In contrast, MFM-P versus IOP was not signifi-
cantly correlated.  Although cataract is a cardinal sign of DM1, 
it generally develops with disease progression, expressed in 
our patients with lower scores of MFM-P. The typical DM1 
lens opacity is named “christman’s tree” cataract, the expres-
sion of iridescent multicolored posterior capsular lens opac-
ity11, at least in earlier stages of its development. This pattern 
is difficult to see in cases with mature cataract5,11,12.
Four patients with genetically proved DM1, aged up to 30 
years, had transparent lenses and were under the mean and 
Table 2. MFM-P results in n = 36 Myotonic Dystrophy type 1 patients.
Case Age (y) D1 (%) D2 (%) D3 (%) Total (%)
1 48 41.02 94.44 95.23 72.91
2 60 33.33 94.44 80.95 66.66
3 36 53.84 83.33 71.42 68.75
4 48 61.53 77.77 66.66 68.75
5 34 66.66 94.44 71.42 78.12
6 57 58.97 88.88 80.95 75.00
7 36 76.92 88.88 85.71 83.33
8 32 97.43 100 90.47 96.87
9 26 97.43 97.22 100 97.91
10 57 79.48 91.66 100 88.54
11 44 35.89 80.55 80.95 62.50
12 34 87.17 86.11 95.23 88.54
13 30 100 100 95.23 98.95
14 34 100 91.66 90.47 94.79
15 45 28.20 77.77 71.42 56.25
16 47 71.79 91.66 85.71 82.29
17 30 64.10 94.44 95.23 82.29
18 31 74.35 97.22 95.23 87.50
19 28 94.87 91.66 95,23 93.75
20 40 38.46 97.22 61.90 65.62
21 34 48.71 80.55 76.19 66.66
22 37 25.64 80.55 80.95 58.33
24 50 17.94 66.66 47.61 42.70
25 60 35.89 88.88 66.66 62.50
26 64 71.79 94.44 95.23 85.41
27 61 25.64 83.33 61.90 55.20
28 23 92.30 97.22 95.23 94.79
29 58 20.51 93.93 61.90 54.16
31 49 79.48 94.44 95.23 88.54
32 40 61.53 88.88 85.71 77.08
33 35 94.87 97.22 95.23 95.83
34 57 33.33 83.33 76.18 61.45
36 17 94.87 97.22 85.71 93.75
38 30 92.30 94.44 95.23 93.75
39 35 51.28 88.88 90.47 73.95
42 39 71.79 86.11 90.47 81.25
Mean 41.28 63.31 89.87 83.59 77.63
SD 12.17 26.27 7.48 13.19 15.07
median 38 65.38 91.66 85.71 79.68
Y: years; MFM-P: motor function measure, Portuguese version; D1: Dimension 1 (standing position and transfers); D2: Dimension 2 (axial and proximal function); 
D3: Dimension 3 (distal function).
187Karin Suzete Ikeda et al. Myotonic dystrophy type 1 and ophthalmology
median age in relation to those with lens opacity. This fact rein-
forces that cataract develops during disease evolution. It is in-
teresting to note that MFM-P scale performed in three of them 
were 93.75% to 98.95%, scores close to normal. Cataract is rare 
in congenital and infantile clinical types of DM1, at least earlier 
in the disease course and in patients under 10 years5.
There are several hypotheses to explain how cataracts de-
velop in patients with DM1: haploinsufficiency of SIX5 gene 
expression13,14, toxicity of DMPK gene products15, instability 
of DMPK gene with repercussion in the expression profile of 
the epithelial cell of lens12. It is important to realize that even 
patients with small CTG expansions may present cataracts, 
and this may be the unique clinical sign in these subjects16. In 
this study, we were not able to correlate the frequency of cat-
aracts with the genotypes because we employed a qualitative 
method (TP-PCR) for most patients and also because some 
patients were not tested directly.
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 Eyelid ptosis, not associated with external ophthalmo-
plegia, was the second most frequent finding in the cohort. It 
was significantly correlated with poor motor performance ex-
pressed by MFM-P scores, which suggests it is a manifestation 
that evolves along disease course. Aring et  al.17 documented 
swollen eyelids ‘pseudoptosis’ in their patients younger than 
18 years, while blepharoptosis was reported to be rare.
Previous reports highlighted low IOP in some patients 
with DM16,18. In these studies, authors hypothesized that 
low IOP could be related either to increased aqueous hu-
mor outflow or decreased aqueous secretion. However, a 
complete pathophysiologic model to explain reduced IOP 
is still not available6,18.
 In our mostly adult cohort, the most common refractive 
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signs in the cohort of DM1 patients, issued from a uni-
versity hospital, included cataract, ptosis, low IOP, and 
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curred in patients with worse motor function as seen by 
MFM-P. IOP occurred independent of disease evolution 
or motor dysfunction.
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